Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$140.25 - $196.86 $219,491 - $308,085
-1,565 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$126.47 - $163.7 $197,925 - $256,190
1,565 New
1,565 $222,000
Q3 2020

Nov 09, 2020

SELL
$87.44 - $125.0 $253,576 - $362,500
-2,900 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$58.39 - $89.31 $169,331 - $258,999
2,900 New
2,900 $259,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Morse Asset Management, Inc Portfolio

Follow Morse Asset Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morse Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morse Asset Management, Inc with notifications on news.